This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: Csl Behring Gmbh, Csl Behring Lengnau Ag. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2021
Title: Uwe Kalina: Innovator in Blood Coagulation Treatments
Introduction
Uwe Kalina is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of blood coagulation disorders through his innovative research and patented inventions. With a total of 3 patents, Kalina's work focuses on improving treatment options for patients suffering from coagulation issues.
Latest Patents
Kalina's latest patents include a modified von Willebrand factor that has an improved half-life. This invention relates to a modified VWF molecule designed for use in treating blood coagulation disorders. Another significant patent involves coagulation factor X polypeptides with modified activation properties. This invention pertains to modified cDNA sequences coding for factor X polypeptides, particularly human factor X and its derivatives. These modifications can bypass the need for either factor VIIIa/factor IXa or factor VIIa/tissue factor for activation. The invention also encompasses recombinant expression vectors containing such modified cDNA sequences, host cells transformed with these vectors, and processes for manufacturing recombinant proteins and their derivatives.
Career Highlights
Throughout his career, Uwe Kalina has worked with prominent companies in the biotechnology sector, including CSL Behring GmbH and CSL Behring Lengnau AG. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of blood coagulation.
Collaborations
Kalina has collaborated with notable colleagues such as Stefan Schulte and Thomas Weimer. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Uwe Kalina's contributions to the field of blood coagulation treatments through his innovative patents highlight his role as a significant inventor. His work continues to impact the medical community and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile